Page 137 - 南京医科大学学报自然科学版

第43卷第4期 朱睿放，张 宇，卢应梅. 小胶质细胞及其介导的神经炎症在帕金森病中的作用［J］.
2023年4月 南京医科大学学报（自然科学版），2023，43（04）：569⁃576 ·575 ·

neuroinflammation and neurodegeneration［J］. Front Bios⁃ ［23］ LIU T W，CHEN C M，CHANG K H. Biomarker of neuro⁃
ci（Schol Ed），2015，7（1）：189-204 inflammation in Parkinson’s disease［J］. Int J Mol Sci，
［10］ STEFANOVA N. Microglia in Parkinson’s disease［J］. J 2022，23（8）：4148
Parkinsons Dis，2022，12（s1）：S105-S112 ［24］ SAHAR R，ULRIKA J，XIONG M F，et al. Reduction of
［11］ BLAGBURN⁃BLANCO S V，CHAPPELL M S，DE BIASE αSYN pathology in a mouse model of PD using a brain⁃
L M，et al. Synapse⁃specific roles for microglia in develop⁃ penetrating bispecific antibody［J］. Pharmaceutics，2022，
ment：new horizons in the prefrontal cortex［J］. Front Mol 14（7）：1412
Neurosci，2022，15：965756 ［25］ DUTTA D，JANA M，MAJUMDER M，et al. Selective tar⁃
［12］ GUO S，WANG H，YIN Y. Microglia polarization from M1 geting of the TLR2/MyD88/NF ⁃ κB pathway reduces α ⁃
to M2 in neurodegenerative diseases［J］. Front Aging Neu⁃ synuclein spreading in vitro and in vivo［J］. Nat Commun，
rosci，2022，14：815347 2021，12（1）：5382
［13］ MCGEER P L，ITAGAKI S，BOYES B E，et al. Reactive ［26］ PIKE A F，VARANITA T，HERREBOUT M A C，et al. α⁃
microglia are positive for HLA⁃DR in the substantia nigra Synuclein evokes NLRP3 inflammasome⁃mediated IL⁃1β
of Parkinson’s and Alzheimer’s disease brains［J］. Neu⁃ secretion from primary human microglia［J］. Glia，2021，
rology，1988，38（8）：1285-1291 69（6）：1413-1428
［14］ GORDON R，ALBORNOZ E A，CHRISTIE D C，et al. In⁃ ［27］ ZHU B，YIN D，ZHAO H，et al. The immunology of Par⁃
flammasome inhibition prevents α ⁃ synuclein pathology kinson’s disease［J］. Semin Immunopathol，2022，44（5）：
and dopaminergic neurodegeneration in mice［J］. Sci 659-672
Transl Med，2018，10（465）：eaah4066 ［28］ ZHANG M，LI C，REN J，et al. The double⁃faceted role of
［15］ RUSSO T，RIESSLAND M. Age⁃related midbrain inflam⁃ leucine⁃rich repeat kinase 2 in the immunopathogenesis
mation and senescence in Parkinson’s disease［J］. Front of Parkinson’s disease［J］. Front Aging Neurosci，2022，
Aging Neurosci，2022，14：917797 14：909303
［16］ ALEXANDER G，NICOLA P，GARY H，et al. In vivo im⁃ ［29］ MAGISTRELLI L，CONTALDI E，VIGNAROLI F，et al.
aging of microglial activation with［11C］（R）⁃ PK11195 Immune response modifications in the genetic forms of
PET in idiopathic Parkinson’s disease［J］. Neurobiol Dis， Parkinson’s disease：what do we know?［J］. Int J Mol Sci，
2006，21（2）：404-412 2022，23（7）：3476
［17］ HARMS A S，FERREIRA S A，ROMERO⁃RAMOS M. Pe⁃ ［30］ GIORGI C，BOUHAMIDA E，DANESE A，et al. Rele⁃
riphery and brain，innate and adaptive immunity in Par⁃ vance of autophagy and mitophagy dynamics and markers
kinson’s disease［J］. Acta Neuropathol，2021，141（4）： in neurodegenerative diseases［J］. Biomedicines，2021，9
527-545 （2）：149
［18］ HEAVENER K S，BRADSHAW E M. The aging immune ［31］SLITER D A，MARTINEZ J，HAO L，et al. Parkin and
system in Alzheimer’s and Parkinson’s diseases［J］. PINK1 mitigate STING⁃induced inflammation［J］. Nature，
Semin Immunopathol，2022，44（5）：649-657 2018，561（7722）：258-262
［19］ YU Z，YANG L，YANG Y，et al. Epothilone B benefits ni⁃ ［32］ PAP D，VERES⁃SZÉKELY A，SZEBENI B，et al. PARK7/
gral dopaminergic neurons by attenuating microglia acti⁃ DJ⁃1 as a therapeutic target in gut⁃brain axis diseases［J］.
vation in the 6⁃hydroxydopamine lesion mouse model of Int J Mol Sci，2022，23（12）：6626
Parkinson’s disease［J］. Front Cell Neurosci，2018，12： ［33］ NEVES M，GRÃOS M，ANJO S I，et al. Modulation of sig⁃
324 naling pathways by DJ⁃1：an updated overview［J］. Redox
［20］ JOHNSON M E，STECHER B，LABRIE V，et al. Triggers， Biol，2022，51：102283
facilitators，and aggravators：redefining Parkinson’s dis⁃ ［34］ JI Y J，WANG H L，YIN B L，et al. Down⁃regulation of DJ⁃
ease pathogenesis［J］. Trends Neurosci，2019，42（1）：4- 1 augments neuroinflammation via Nrf2/Trx1/NLRP3 axis
13 in MPTP⁃induced Parkinson’s disease mouse model［J］.
［21］ DINTER E，SARIDAKI T，DIEDERICHS L，et al. Parkin⁃ Neuroscience，2020，442：253-263
son’s disease and translational research［J］. Transl Neu⁃ ［35］ JOERS V，TANSEY M G，MULAS G，et al. Microglial
rodegener，2020，9（1）：43 phenotypes in Parkinson’s disease and animal models of
［22］ PARMAR M. Targets for astrocyte ⁃ based treatments of the disease［J］. Prog Neurobiol，2017，155：57-75
Parkinson’s disease（PD）［J］. PNAS，2022，119（30）： ［36］ CHE Y，HOU L，SUN F，et al. Taurine protects dopami⁃
e2208876119 nergic neurons in a mouse Parkinson’s disease model